Concepedia

Michael Danilenko

MD

Statistics

Publications

52

Citations

4K

H-Index

30

Active since

1993

Affiliations

Ben-Gurion University of the Negev(Current)

Soroka Medical Center

Rutgers, The State University of New Jersey

Rutgers New Jersey Medical School

University Hospital, Newark

Michael Danilenko is an author at Ben-Gurion University of the Negev specializing in oncology, medicine, and molecular oncology.

Publications per year

1993–2021

52

Publications

52

Lycopene is a more potent inhibitor of human cancer cell proliferation than either α‐carotene or β‐carotene

J Lévy, E Bosin, Bianca Feldman et al. · Nutrition and Cancer · 1995 · 509 citations

Medicine, Oncology, Pharmacology +10

Lycopene Interferes With Cell Cycle Progression and Insulin-Like Growth Factor I Signaling in Mammary Cancer Cells

Michael Karas, Hadar Amir, Daniel Fishman et al. · Nutrition and Cancer · 2000 · 332 citations

Medicine, Cancer Biology, Oncology +13

Carotenoids activate the antioxidant response element transcription system

Anat Ben-Dor, Michael Steiner, Larisa Gheber et al. · Molecular Cancer Therapeutics · 2005 · 318 citations · Full text

Life Sciences, Biochemistry, Oncology +11

Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27Kip1 in the cyclin E–cdk2 complexes

Amit Nahum, Keren Hirsch, Michael Danilenko et al. · Oncogene · 2001 · 234 citations

Life Sciences, Cell Biology, Oncology +17

Lycopene and 1,25‐dihydroxyvitamin d<sub>3</sub>cooperate in the inhibition of cell cycle progression and induction of differentiation in hl‐60 leukemic cells

Hadar Amir, Michael Karas, Judith Giat et al. · Nutrition and Cancer · 1999 · 213 citations

Life Sciences, Cell Biology, Oncology +11

1–5 of 52